Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business
Wuxi Pharmatech (Cayman) Inc. - SWOT Analysis

Wuxi Pharmatech (Cayman) Inc. - financial and operations analysis - new market and company analysis


Print article Print article
Refer this article Refer to a friend
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2009-09-18 11:31:01 - Wuxi Pharmatech (Cayman) Inc. - SWOT Analysis - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/wuxi-pharmat ..(cayman)-inc.-swot-analysis-157294.asp

The Wuxi Pharmatech (Cayman) Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Wuxi Pharmatech (Cayman) Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Wuxi Pharmatech (Cayman) (WuXi) is a leading global pharmaceutical, biopharmaceutical and

medical device outsourcing company. It offers a range of laboratory and manufacturing services across the discovery-to-commercialization spectrum. The company primarily operates in China and the US. It is headquartered in Shanghai, China and employs about 3,800 people. The company recorded revenues of $253.5 million during the financial year (FY) ended December 2008, an increase of 87.5% over FY2007. The increase was due to rise in laboratory services contracts. The operating loss of the company was $20.9 million during FY2008, as compared to the operating profit of $30.2 million in FY2007. The net loss of the company was $64.2 million in FY2008, as compared to the net profit of $33.9 million in FY2007.

Scope of the Report

- Provides all the crucial information on Wuxi Pharmatech (Cayman) Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Wuxi Pharmatech (Cayman) Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Wuxi Pharmatech (Cayman) Inc.
-Data is supplemented with details on Wuxi Pharmatech (Cayman) Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Wuxi Pharmatech (Cayman) Inc.

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Terms & Conditions | Privacy | About us | Contact PR-inside.com